Conference - Philadelphia, PA, United States
With so many recent advances in treating metastatic melanoma, including approaches like immunotherapies, targeted therapies, and combination therapies, melanoma research is at a critical point where it is extremely important for the field to have a continuous exchange of information. Despite the success of various “targeted” inhibitors, therapeutic responses in melanoma patients are often short-lived due to rapidly acquired drug resistance. Therefore, it is essential that melanoma researchers translate the novel understanding of melanoma biology to decipher the mechanisms of innate and acquired drug resistance for the development of improved therapeutic options. To bridge the gap between scientists and clinician-scientists’ professional practice, this Special Conference will provide a platform for discussion and potential collaborations for the discovery of new therapeutic targets.
Organization: American Association for Cancer Research
Scientific Conferences 2014 - Advances in Melanoma: From Biology to Therapy
Sat, Sep 20, 2014 - Tue, Sep 23, 2014
Loews Philadelphia
Philadelphia, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
